Global Pharmacovigilance Services Market Research Report 2022-2028

Global Pharmacovigilance Services Market Research Report 2022-2028

Report Code: KNJ1408927 | No. of Pages: 130 | Category: Services
Publisher: Maia Research | Date of Publish: Sep-2022
This report studies the global Pharmacovigilance Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pharmacovigilance Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmacovigilance Services that contribute to its increasing demand across many markets.

The global Pharmacovigilance Services market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study
Global Pharmacovigilance Services total market, 2017-2028, (USD Million)
Global Pharmacovigilance Services total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Pharmacovigilance Services total market, key domestic companies and share, (USD Million)
Global Pharmacovigilance Services revenue by player and market share 2017-2022, (USD Million)
Global Pharmacovigilance Services total market by Type, CAGR, 2017-2028, (USD Million)
Global Pharmacovigilance Services total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Pharmacovigilance Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PrimeVigilance, Quanticate, ProPharma, Parexel, Accenture, SOTERIUS, SGS, Medpace and PPD, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmacovigilance Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Pharmacovigilance Services Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pharmacovigilance Services Market, Segmentation by Type
    Adverse Event Case Management
    Aggregate Reporting
    Signal Intelligence
    Risk Management

Global Pharmacovigilance Services Market, Segmentation by Application
    Biotechnology and Pharmaceuticals
    Contract Research Organization
    Hospital
    KPO / BPO
    Healthcare Institutions
    Others

Companies Profiled:
    PrimeVigilance
    Quanticate
    ProPharma
    Parexel
    Accenture
    SOTERIUS
    SGS
    Medpace
    PPD
    QVigilance
    Freyr Solutions
    Navitas Life Sciences
    MMS Holdings
    Amarex
    Astrix Technology Group
    Cambridge Regulatory Services
    CROMSOURCE
    APCER Life Sciences
    Pharmya
    A+Science
    Midas Pharma
    George Clinical
    Syneos Health
    INPHARMATIS
    Taimei Technology
    Extedo
    WCG Clinical

Key Questions Answered
1. How big is the global Pharmacovigilance Services market?
2. What is the demand of the global Pharmacovigilance Services market?
3. What is the year over year growth of the global Pharmacovigilance Services market?
4. What is the total value of the global Pharmacovigilance Services market?
5. Who are the major players in the global Pharmacovigilance Services market?
6. What are the growth factors driving the market demand?
1 Supply Summary
    1.1 Pharmacovigilance Services Introduction
    1.2 World Pharmacovigilance Services Market Size & Forecast (2017 & 2021 & 2028)
    1.3 World Pharmacovigilance Services Total Market by Region
        1.3.1 World Pharmacovigilance Services Market Size by Region (2017-2028)
        1.3.2 United States Pharmacovigilance Services Market Size (2017-2028)
        1.3.3 China Pharmacovigilance Services Market Size (2017-2028)
        1.3.4 Europe Pharmacovigilance Services Market Size (2017-2028)
        1.3.5 Japan Pharmacovigilance Services Market Size (2017-2028)
        1.3.6 South Korea Pharmacovigilance Services Market Size (2017-2028)
        1.3.7 ASEAN Pharmacovigilance Services Market Size (2017-2028)
        1.3.8 India Pharmacovigilance Services Market Size (2017-2028)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pharmacovigilance Services Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pharmacovigilance Services Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 World Pharmacovigilance Services Companies Competitive Analysis
    2.1 World Pharmacovigilance Services Revenue by Player (2017-2022)
    2.2 Industry Rank and Concentration Rate (CR)
        2.2.1 Global Pharmacovigilance Services Industry Rank of Major Players
        2.2.2 Global Concentration Ratios (CR4) for Pharmacovigilance Services in 2021
        2.2.3 Global Concentration Ratios (CR8) for Pharmacovigilance Services in 2021
    2.3 Pharmacovigilance Services Company Evaluation Quadrant
    2.4 Pharmacovigilance Services Market: Overall Company Footprint Analysis
        2.4.1 Pharmacovigilance Services Market: Region Footprint
        2.4.2 Pharmacovigilance Services Market: Company Product Type Footprint
        2.4.3 Pharmacovigilance Services Market: Company Product Application Footprint
    2.5 Competitive Environment
        2.5.1 Historical Structure of the Industry
        2.5.2 Barriers of Market Entry
        2.5.3 Factors of Competition
    2.6 Mergers, Acquisitions Activity

3 United States VS China VS Rest of the World
    3.1 United States VS China: Pharmacovigilance Services Market Comparison
        3.1.1 United States VS China: Pharmacovigilance Services Market Size Comparison (2017 & 2021 & 2028)
        3.1.2 United States VS China: Pharmacovigilance Services Market Size Market Share Comparison (2017 & 2021 & 2028)
    3.2 United States Pharmacovigilance Services Major Players and Market Share, 2017-2022
        3.2.1 Major Players of Pharmacovigilance Services in United States, Headquarters (States, Country)
        3.2.2 United States Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
    3.3 China Pharmacovigilance Services Major Players and Market Share, 2017-2022
        3.3.1 Major Players of Pharmacovigilance Services in China, Headquarters (Province, Country)
        3.3.2 China Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
    3.4 Rest of World Pharmacovigilance Services Major Players and Market Share, 2017-2022
        3.4.1 Major Players of Pharmacovigilance Services in Rest of World, Headquarters (State, Country)
        3.4.2 Rest of World Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)

4 Market Analysis by Type
    4.1 World Pharmacovigilance Services Market Size Overview by Type: 2017 VS 2021 VS 2028
    4.2 Segment Introduction by Type
        4.2.1 Adverse Event Case Management
        4.2.2 Aggregate Reporting
        4.2.3 Signal Intelligence
        4.2.4 Risk Management
    4.3 Market Segment by Type
        4.3.1 World Pharmacovigilance Services Market Size by Type (2017-2022)
        4.3.2 World Pharmacovigilance Services Market Size by Type (2023-2028)
        4.3.3 World Pharmacovigilance Services Market Size Market Share by Type (2017-2028)

5 Market Analysis by Application
    5.1 World Pharmacovigilance Services Market Size Overview by Application: 2017 VS 2021 VS 2028
    5.2 Segment Introduction by Application
        5.2.1 Biotechnology and Pharmaceuticals
        5.2.2 Contract Research Organization
        5.2.3 Hospital
        5.2.4 KPO / BPO
        5.2.5 KPO / BPO
        5.2.6 Others
    5.3 Market Segment by Application
        5.3.1 World Pharmacovigilance Services Market Size by Application (2017-2022)
        5.3.2 World Pharmacovigilance Services Market Size by Application (2023-2028)
        5.3.3 World Pharmacovigilance Services Market Size by Application (2017-2028)

6 Company Profiles
    6.1 PrimeVigilance
        6.1.1 PrimeVigilance Details
        6.1.2 PrimeVigilance Major Business
        6.1.3 PrimeVigilance Pharmacovigilance Services Product and Services
        6.1.4 PrimeVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.1.5 PrimeVigilance Recent Developments/Updates
        6.1.6 PrimeVigilance Competitive Strengths & Weaknesses
    6.2 Quanticate
        6.2.1 Quanticate Details
        6.2.2 Quanticate Major Business
        6.2.3 Quanticate Pharmacovigilance Services Product and Services
        6.2.4 Quanticate Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.2.5 Quanticate Recent Developments/Updates
        6.2.6 Quanticate Competitive Strengths & Weaknesses
    6.3 ProPharma
        6.3.1 ProPharma Details
        6.3.2 ProPharma Major Business
        6.3.3 ProPharma Pharmacovigilance Services Product and Services
        6.3.4 ProPharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.3.5 ProPharma Recent Developments/Updates
        6.3.6 ProPharma Competitive Strengths & Weaknesses
    6.4 Parexel
        6.4.1 Parexel Details
        6.4.2 Parexel Major Business
        6.4.3 Parexel Pharmacovigilance Services Product and Services
        6.4.4 Parexel Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.4.5 Parexel Recent Developments/Updates
        6.4.6 Parexel Competitive Strengths & Weaknesses
    6.5 Accenture
        6.5.1 Accenture Details
        6.5.2 Accenture Major Business
        6.5.3 Accenture Pharmacovigilance Services Product and Services
        6.5.4 Accenture Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.5.5 Accenture Recent Developments/Updates
        6.5.6 Accenture Competitive Strengths & Weaknesses
    6.6 SOTERIUS
        6.6.1 SOTERIUS Details
        6.6.2 SOTERIUS Major Business
        6.6.3 SOTERIUS Pharmacovigilance Services Product and Services
        6.6.4 SOTERIUS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.6.5 SOTERIUS Recent Developments/Updates
        6.6.6 SOTERIUS Competitive Strengths & Weaknesses
    6.7 SGS
        6.7.1 SGS Details
        6.7.2 SGS Major Business
        6.7.3 SGS Pharmacovigilance Services Product and Services
        6.7.4 SGS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.7.5 SGS Recent Developments/Updates
        6.7.6 SGS Competitive Strengths & Weaknesses
    6.8 Medpace
        6.8.1 Medpace Details
        6.8.2 Medpace Major Business
        6.8.3 Medpace Pharmacovigilance Services Product and Services
        6.8.4 Medpace Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.8.5 Medpace Recent Developments/Updates
        6.8.6 Medpace Competitive Strengths & Weaknesses
    6.9 PPD
        6.9.1 PPD Details
        6.9.2 PPD Major Business
        6.9.3 PPD Pharmacovigilance Services Product and Services
        6.9.4 PPD Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.9.5 PPD Recent Developments/Updates
        6.9.6 PPD Competitive Strengths & Weaknesses
    6.10 QVigilance
        6.10.1 QVigilance Details
        6.10.2 QVigilance Major Business
        6.10.3 QVigilance Pharmacovigilance Services Product and Services
        6.10.4 QVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.10.5 QVigilance Recent Developments/Updates
        6.10.6 QVigilance Competitive Strengths & Weaknesses
    6.11 Freyr Solutions
        6.11.1 Freyr Solutions Details
        6.11.2 Freyr Solutions Major Business
        6.11.3 Freyr Solutions Pharmacovigilance Services Product and Services
        6.11.4 Freyr Solutions Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.11.5 Freyr Solutions Recent Developments/Updates
        6.11.6 Freyr Solutions Competitive Strengths & Weaknesses
    6.12 Navitas Life Sciences
        6.12.1 Navitas Life Sciences Details
        6.12.2 Navitas Life Sciences Major Business
        6.12.3 Navitas Life Sciences Pharmacovigilance Services Product and Services
        6.12.4 Navitas Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.12.5 Navitas Life Sciences Recent Developments/Updates
        6.12.6 Navitas Life Sciences Competitive Strengths & Weaknesses
    6.13 MMS Holdings
        6.13.1 MMS Holdings Details
        6.13.2 MMS Holdings Major Business
        6.13.3 MMS Holdings Pharmacovigilance Services Product and Services
        6.13.4 MMS Holdings Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.13.5 MMS Holdings Recent Developments/Updates
        6.13.6 MMS Holdings Competitive Strengths & Weaknesses
    6.14 Amarex
        6.14.1 Amarex Details
        6.14.2 Amarex Major Business
        6.14.3 Amarex Pharmacovigilance Services Product and Services
        6.14.4 Amarex Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.14.5 Amarex Recent Developments/Updates
        6.14.6 Amarex Competitive Strengths & Weaknesses
    6.15 Astrix Technology Group
        6.15.1 Astrix Technology Group Details
        6.15.2 Astrix Technology Group Major Business
        6.15.3 Astrix Technology Group Pharmacovigilance Services Product and Services
        6.15.4 Astrix Technology Group Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.15.5 Astrix Technology Group Recent Developments/Updates
        6.15.6 Astrix Technology Group Competitive Strengths & Weaknesses
    6.16 Cambridge Regulatory Services
        6.16.1 Cambridge Regulatory Services Details
        6.16.2 Cambridge Regulatory Services Major Business
        6.16.3 Cambridge Regulatory Services Pharmacovigilance Services Product and Services
        6.16.4 Cambridge Regulatory Services Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.16.5 Cambridge Regulatory Services Recent Developments/Updates
        6.16.6 Cambridge Regulatory Services Competitive Strengths & Weaknesses
    6.17 CROMSOURCE
        6.17.1 CROMSOURCE Details
        6.17.2 CROMSOURCE Major Business
        6.17.3 CROMSOURCE Pharmacovigilance Services Product and Services
        6.17.4 CROMSOURCE Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.17.5 CROMSOURCE Recent Developments/Updates
        6.17.6 CROMSOURCE Competitive Strengths & Weaknesses
    6.18 APCER Life Sciences
        6.18.1 APCER Life Sciences Details
        6.18.2 APCER Life Sciences Major Business
        6.18.3 APCER Life Sciences Pharmacovigilance Services Product and Services
        6.18.4 APCER Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.18.5 APCER Life Sciences Recent Developments/Updates
        6.18.6 APCER Life Sciences Competitive Strengths & Weaknesses
    6.19 Pharmya
        6.19.1 Pharmya Details
        6.19.2 Pharmya Major Business
        6.19.3 Pharmya Pharmacovigilance Services Product and Services
        6.19.4 Pharmya Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.19.5 Pharmya Recent Developments/Updates
        6.19.6 Pharmya Competitive Strengths & Weaknesses
    6.20 A+Science
        6.20.1 A+Science Details
        6.20.2 A+Science Major Business
        6.20.3 A+Science Pharmacovigilance Services Product and Services
        6.20.4 A+Science Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.20.5 A+Science Recent Developments/Updates
        6.20.6 A+Science Competitive Strengths & Weaknesses
    6.21 Midas Pharma
        6.21.1 Midas Pharma Details
        6.21.2 Midas Pharma Major Business
        6.21.3 Midas Pharma Pharmacovigilance Services Product and Services
        6.21.4 Midas Pharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.21.5 Midas Pharma Recent Developments/Updates
        6.21.6 Midas Pharma Competitive Strengths & Weaknesses
    6.22 George Clinical
        6.22.1 George Clinical Details
        6.22.2 George Clinical Major Business
        6.22.3 George Clinical Pharmacovigilance Services Product and Services
        6.22.4 George Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.22.5 George Clinical Recent Developments/Updates
        6.22.6 George Clinical Competitive Strengths & Weaknesses
    6.23 Syneos Health
        6.23.1 Syneos Health Details
        6.23.2 Syneos Health Major Business
        6.23.3 Syneos Health Pharmacovigilance Services Product and Services
        6.23.4 Syneos Health Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.23.5 Syneos Health Recent Developments/Updates
        6.23.6 Syneos Health Competitive Strengths & Weaknesses
    6.24 INPHARMATIS
        6.24.1 INPHARMATIS Details
        6.24.2 INPHARMATIS Major Business
        6.24.3 INPHARMATIS Pharmacovigilance Services Product and Services
        6.24.4 INPHARMATIS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.24.5 INPHARMATIS Recent Developments/Updates
        6.24.6 INPHARMATIS Competitive Strengths & Weaknesses
    6.25 Taimei Technology
        6.25.1 Taimei Technology Details
        6.25.2 Taimei Technology Major Business
        6.25.3 Taimei Technology Pharmacovigilance Services Product and Services
        6.25.4 Taimei Technology Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.25.5 Taimei Technology Recent Developments/Updates
        6.25.6 Taimei Technology Competitive Strengths & Weaknesses
    6.26 Extedo
        6.26.1 Extedo Details
        6.26.2 Extedo Major Business
        6.26.3 Extedo Pharmacovigilance Services Product and Services
        6.26.4 Extedo Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.26.5 Extedo Recent Developments/Updates
        6.26.6 Extedo Competitive Strengths & Weaknesses
    6.27 WCG Clinical
        6.27.1 WCG Clinical Details
        6.27.2 WCG Clinical Major Business
        6.27.3 WCG Clinical Pharmacovigilance Services Product and Services
        6.27.4 WCG Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
        6.27.5 WCG Clinical Recent Developments/Updates
        6.27.6 WCG Clinical Competitive Strengths & Weaknesses

7 Raw Material and Industry Chain
    7.1 Raw Material of Pharmacovigilance Services and Key Manufacturers
    7.2 Pharmacovigilance Services Manufacturing Costs
    7.3 Pharmacovigilance Services Production Process
    7.4 Pharmacovigilance Services Industrial Chain

8 Distribution Channel Analysis
    8.1 Distribution Channel Breakdown for Pharmacovigilance Services Shipments (%): 2017-2028
        8.1.1 Direct Channel
        8.1.2 Indirect Channel
    8.2 Pharmacovigilance Services Typical Distributors
    8.3 Pharmacovigilance Services Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com